Late Word on Stents--And Friday on cnbc.com
Senior Editor, CNBC
There's late word from CNBC's Mike Huckman. He reported in "Closing Bell' that the FDA stent conference came out in support of drug-coated stents. There had been concerns the drug-coated stents caused blood clots--and the metal stents did not. But the FDA says the proof is inconclusive. Stents are implanted in patients to stop heart attacks. Mike will have a follow up tomorrow on this late news.
This is good news for companies who make those drug-coated stents--like Johnson & Johnson and Boston Scientific .
And for tomorrow--we'll have a few guests you'll be interested in. That includes U.S.Treasury Secretary Henry Paulson. He'll be on "Power Lunch" to talk about China and the U.S. employment numbers. Those numbers could be a real barometer for the U.S. economy. They're out in the morning.
We'll also have Abby Joseph Cohn from Goldman Sachs with a look at the S&P.
